Aurobindo Pharma’s scrip zooms 8%

Our Bureau. Hyderabad | Updated on January 25, 2021 Published on January 25, 2021

Shares of Aurobindo Pharma surged 8 per cent on the BSE on Monday to ₹998 on incentive booster. The company’s project for production of penicillin G has been approved by the Centre under the Production Linked Incentive scheme for promoting domestic manufacture of bulk drugs and active pharmaceutical ingredients.

The project has a committed production capacity of 15,000 tonnes of penicillin G with an investment of ₹1,392 crore.

The commercial production is projected to commence from 2023-24. The project will also enhance the company's backward integration in antibiotics and open-up new revenue streams to support its growth prospects, said analysts.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 25, 2021
This article is closed for comments.
Please Email the Editor